Format

Send to

Choose Destination
Endocr Connect. 2018 Nov 1. pii: EC-18-0499. doi: 10.1530/EC-18-0499. [Epub ahead of print]

Reduced expression of thyroid hormone receptor β in human nonalcoholic steatohepatitis.

Author information

1
C Krause, Lübeck, Germany.
2
M Grohs, Lübeck, Germany.
3
A El Gammal, Hamburg, Germany.
4
S Wolter, Hamburg, Germany.
5
H Lehnert, Lübeck, Germany.
6
O Mann, Hamburg, Germany.
7
J Mittag, Lübeck, 23562, Germany.
8
H Kirchner, Lübeck, Germany.

Abstract

Hepatic thyroid hormone signaling has an important role in the development and progression of nonalcoholic steatohepatitis (NASH). While the systemic levels of thyroid hormone might remain stable, there is evidence that the intracellular signaling machinery consisting of transporters, deiodinases and receptors could be altered in NASH. However, clinical material from human liver biopsies of individuals with NASH has not been studied to date. In a crossectional study, we analyzed 85 liver biopsies from patients with different stages of NASH that underwent bariatric surgery. Using qPCR, we analyzed gene expression of thyroid hormone transporters NTCP (SLC10A1), MCT8 (SLC16A2), and OATP1C1 (SLCO1C1), thyroid hormone receptor α and β (THRA and THRB) and deiodinase type I, II and III (DIO1, DIO2, DIO3). The expression was correlated with serum TSH, triglyceride, HbA1c, and NASH score and corrected for age or gender if required. While DIO2, DIO3, and SLCO1C1 were not expressed in human liver, we observed a significant negative correlation of THRB and DIO1 with age, and SLC16A2 with gender. THRB expression was also negatively associated with serum triglyceride levels and HbA1c. More importantly, its expression was inversely correlated with NASH score and further declined with age. Our data provide unique insight into the mRNA expression of thyroid hormone transporters, deiodinases and receptors in the human liver. The findings allow important conclusions on the intrahepatic mechanisms governing thyroid hormone action, indicating a possible tissue resistance to the circulating hormone in NASH, which becomes more prominent in advanced age.

Supplemental Content

Full text links

Icon for Sheridan PubFactory Icon for PubMed Central
Loading ...
Support Center